Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFM.L Regulatory News (AFM)

  • There is currently no data for AFM

Director/PDMR Shareholding

2 Dec 2020 07:00

RNS Number : 1992H
Alpha Fin Markets Consulting plc
02 December 2020
 

2 December 2020

Alpha Financial Markets Consulting plc

('Alpha FMC', 'Alpha', the 'Company' or 'Group')

PDMR dealing

 

Alpha FMC (AIM: AFM), a leading global provider of specialist consultancy services to the Asset and Wealth Management industry, announces that it has been notified that Euan Fraser, Global Chief Executive Officer, sold on 27 and 30 November 2020 a total of 1,042,596 ordinary shares of 0.075p each ('Ordinary Shares') in the Company, following the third anniversary of the Company's IPO and admission to trading on AIM.

Following this sale, Euan Fraser holds 615,637 MIP options and JSOP Shares awards and he and his immediate family are beneficially interested in 563,485 Ordinary Shares representing 0.55% of the Company's total voting rights.

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide additional detail. 

Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMR) and persons closely associated with them (PCA) required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Euan Fraser

2

Reason for the notification

a)

Position/status

Global Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Alpha Financial Markets Consulting plc

b)

LEI

2138003XGYCLWLC7GF39

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 0.075p each ('Ordinary Shares')

 

ISIN: GB00BF16C058

b)

Nature of the transaction

Sale of Ordinary Shares

 c)

Price(s) and volume(s)

27 November 2020

30 November 2020

Price

Volume

Totals

£2.30

£2.30

924,947

117,649

£2,127,378.10

£270,592.70

d)

Aggregated information

1,042,596 shares sold at £2.30 per share totalling £2,397,970.80

 

Date of the transaction(s)

27 & 30 November 2020

f)

Place of the transaction(s)

AIM, LSE

 

 Enquiries:

Alpha Financial Markets Consulting plc

+44 (0)20 7796 9300

Euan Fraser, Global Chief Executive Officer

John Paton, Chief Financial Officer

Grant Thornton UK LLP (Nominated Adviser)

+44 (0)20 7383 5100

Philip Secrett

Harrison Clarke

Seamus Fricker

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Chris Bowman

Toby Flaux

Alix Mecklenburg-Solodkoff

Investec Bank plc (Joint Broker)

+44 (0)20 7597 4000

Patrick Robb

James Rudd

Will Fenby

 

Temple Bar Advisory (Public Relations)

Alex Child-Villiers

+44 (0)7795 425 580

William Barker

+44 (0)7827 960 151

Sam Livingstone

+44 (0)7769 655 437

Prism Cosec (Company Secretary)

+44 (0)7407 733 518

Sally Chandler

 

About Alpha FMC:

Alpha FMC is a leading global provider of specialist consultancy services to the asset and wealth management industry.

With over 430 consultants across twelve offices spanning the UK, Europe, North America and Asia, Alpha FMC has the largest dedicated team in the industry. Alpha FMC has provided consultancy services to over 400 clients, including 85% of the 20 largest global asset managers by AUM and a range of other buy-side firms.

- ENDS -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFSLFFLLIII
Date   Source Headline
8th Jan 20247:01 amRNSTR-1: Notification of major holdings
8th Jan 20247:00 amRNSTR-1: Notification of major holdings
24th Nov 202311:32 amRNSInvestor Presentation via Investor Meet Company
23rd Nov 20237:00 amRNSInterim Results
19th Oct 20237:00 amRNSInvestor Presentation via Investor Meet Company
10th Oct 20237:00 amRNSPre-close trading update
26th Sep 202312:33 pmRNSTR-1: Notification of major holdings
31st Aug 20233:33 pmRNSHolding(s) in Company
17th Aug 202312:00 pmRNSExercise of share awards and total voting rights
4th Aug 20237:00 amRNSPublication of ARA and Notice of AGM
1st Aug 20237:00 amRNSTotal Voting Rights
5th Jul 20237:00 amRNSGrant of incentive awards, new shares and TVR
23rd Jun 20237:00 amRNSRSU vesting, PDMR dealing and total voting rights
22nd Jun 20237:00 amRNSFull Year Audited Results
2nd May 20237:00 amRNSAcquisition of Shoreline
11th Apr 20237:00 amRNSHolding(s) in Company
3rd Apr 20237:01 amRNSConfirmation of Chief Executive Officer Start Date
3rd Apr 20237:00 amRNSTotal Voting Rights
9th Mar 20237:00 amRNSTrading update and Capital Markets presentation
1st Mar 20237:00 amRNSTotal Voting Rights
23rd Feb 20239:00 amRNSExercise of share awards and total voting rights
3rd Jan 20237:00 amRNSTotal Voting Rights
2nd Dec 202212:17 pmRNSHolding(s) in Company
30th Nov 20227:00 amRNSExercise of options and issue of equity
23rd Nov 202212:01 pmEQSAlpha FMC growing quickly five years on from AIM listing
23rd Nov 20227:01 amRNSChief Executive Officer Succession
23rd Nov 20227:00 amRNSInterim Results
11th Nov 20224:41 pmRNSSecond Price Monitoring Extn
11th Nov 20224:36 pmRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSVesting of options and total voting rights
11th Oct 20227:00 amRNSPre-close trading update
13th Sep 202212:56 pmRNSResult of AGM
5th Sep 20227:00 amRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
25th Aug 20227:00 amRNSExercise of share awards and total voting rights
1st Aug 20227:00 amRNSTotal Voting Rights
29th Jul 20225:00 pmRNSPublication of Annual Report and Notice of AGM
15th Jul 20227:00 amRNSHolding(s) in Company
11th Jul 202212:00 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSPDMR dealing
4th Jul 20227:00 amRNSIssue of new shares, grant of incentive awards
1st Jul 20227:00 amRNSTotal Voting Rights
28th Jun 20227:00 amRNSExercise of options and total voting rights
23rd Jun 20227:00 amRNSFull Year Audited Results
19th Apr 202212:00 pmRNSHolding(s) in Company
7th Apr 20227:01 amRNSNon-Executive Director Appointment
7th Apr 20227:00 amRNSTrading Update
4th Apr 20227:00 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSTotal Voting Rights
23rd Mar 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.